-1.png)
Early-stage development needs to be fast-paced and is inherently unpredictable. Evidence emerges, priorities evolve, and both sponsors and partners need to adapt quickly to keep advancing therapeutic compounds swiftly toward the patients who need them, with a consistent quality profile.
Piramal has developed a novel process to prepare gliflozins. The new platform technology, which can be applied to any of the gliflozins, involves in-situ reactions with high yields and purity and brings down the cost of manufacturing substantially as compared to prior processes.
Energy Reduction in API Development & Manufacturing
The solvent efficiency improvement initiative at the piramal pharma solutions (pps) digwal, india si...
Site Transfer of Two Products
